New study below [1].
It appears in the journal "Sports Medicine - Open", where authors pay to be published, although the papers are peer reviewed.
But "Sports Medicine"? Isn't that akin to paying someone to bury your PCa paper in the middle of the Sahara?
Perhaps not, if you are still reading.
Some background: When a tumor outgrows its blood supply, hypoxia occurs in cells. Contrary to many internet sites, cancer does not "hate" oxygen. Cells respond to hypoxia via Hypoxia Inducible Factor 1alpha [HIF-1a]. One of the things that HIF-1a does is to cause the production of vascular endothelial growth factor (VEGF), which stimulates the formation of blood vessels.
But HIF-1a causes the production of over 200 other proteins that have a role in cell survival. {This is good if you fly from sea level to Colorago Springs (>1 mile high) with the intention of running up Pike's Peak (>14,000'). But PCa can induce HIF-1a even if there is no hypoxia, and the cell survival proteins offer a formidable barrier to all treatment drugs - & radiation.
It should be noted that some about to begin radiation treatment already have a HIF-1a issue, due to prior therapy.
Note also that castration 'therapy' reduces the red blood cell count (stay clear of Pike's Peak), making HIF-1a more likely.
The authors believe that exercise might help:
"Modulating Tumour Hypoxia in Prostate Cancer Through Exercise: The Impact of Redox Signalling on Radiosensitivity"
I just had my annual medical (RBC: 3.49; Hemoglobin: 11.9 g/dL; Hematocrit: 36.1% - all low) & I'm a bit dubious.
I am sporting a nitroglycerine patch, however. I'm doing my best to inhibit/reverse HIF-1a by improving the oxygen flow.
-Patrick
[1] pubmed.ncbi.nlm.nih.gov/353...
Sports Med Open
. 2022 Apr 8;8(1):48. doi: 10.1186/s40798-022-00436-9.
Modulating Tumour Hypoxia in Prostate Cancer Through Exercise: The Impact of Redox Signalling on Radiosensitivity
Malcolm Brown 1 , Amélie Rébillard 2 , Nicolas H Hart 3 4 5 , Dominic O'Connor 6 , Gillian Prue 7 , Joe M O'Sullivan 8 , Suneil Jain 8
Affiliations collapse
Affiliations
1 School of Nursing and Midwifery, Queen's University Belfast, Northern Ireland, Belfast, UK. m.brown@qub.ac.uk.
2 Movement, Sport and Health Sciences Laboratory, Université Rennes 2, ENS Rennes, Bruz, France.
3 College of Nursing and Health Sciences, Flinders University, Adelaide, SA, Australia.
4 School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia.
5 Institute for Health Research, University of Notre Dame Australia, Perth, WA, Australia.
6 School of Health Sciences, University of Nottingham, Nottingham, England, UK.
7 School of Nursing and Midwifery, Queen's University Belfast, Northern Ireland, Belfast, UK.
8 The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, UK.
PMID: 35394236 DOI: 10.1186/s40798-022-00436-9
Abstract
Prostate cancer is a complex disease affecting millions of men globally. Radiotherapy (RT) is a common treatment modality although treatment efficacy is dependent upon several features within the tumour microenvironment (TME), especially hypoxia. A hypoxic TME heightens radioresistance and thus disease recurrence and treatment failure continues to pose important challenges. However, the TME evolves under the influence of factors in systemic circulation and cellular crosstalk, underscoring its potential to be acutely and therapeutically modified. Early preclinical evidence suggests exercise may affect tumour growth and some of the benefits drawn, could act to radiosensitise tumours to treatment. Intracellular perturbations in skeletal muscle reactive oxygen species (ROS) stimulate the production of numerous factors that can exert autocrine, paracrine, and endocrine effects on the prostate. However, findings supporting this notion are limited and the associated mechanisms are poorly understood. In light of this preclinical evidence, we propose systemic changes in redox signalling with exercise activate redox-sensitive factors within the TME and improve tumour hypoxia and treatment outcomes, when combined with RT. To this end, we suggest a connection between exercise, ROS and tumour growth kinetics, highlighting the potential of exercise to sensitise tumour cells to RT, and improve treatment efficacy.
Keywords: Exercise; Hypoxia; Prostate cancer; Radiotherapy; Reactive oxygen species; Skeletal muscle.
© 2022. The Author(s).
. 2022 Apr 8;8(1):48. doi: 10.1186/s40798-022-00436-9.
Modulating Tumour Hypoxia in Prostate Cancer Through Exercise: The Impact of Redox Signalling on Radiosensitivity
Malcolm Brown 1 , Amélie Rébillard 2 , Nicolas H Hart 3 4 5 , Dominic O'Connor 6 , Gillian Prue 7 , Joe M O'Sullivan 8 , Suneil Jain 8
Affiliations collapse
Affiliations
1 School of Nursing and Midwifery, Queen's University Belfast, Northern Ireland, Belfast, UK. m.brown@qub.ac.uk.
2 Movement, Sport and Health Sciences Laboratory, Université Rennes 2, ENS Rennes, Bruz, France.
3 College of Nursing and Health Sciences, Flinders University, Adelaide, SA, Australia.
4 School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia.
5 Institute for Health Research, University of Notre Dame Australia, Perth, WA, Australia.
6 School of Health Sciences, University of Nottingham, Nottingham, England, UK.
7 School of Nursing and Midwifery, Queen's University Belfast, Northern Ireland, Belfast, UK.
8 The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, UK.
PMID: 35394236 DOI: 10.1186/s40798-022-00436-9
Abstract
Prostate cancer is a complex disease affecting millions of men globally. Radiotherapy (RT) is a common treatment modality although treatment efficacy is dependent upon several features within the tumour microenvironment (TME), especially hypoxia. A hypoxic TME heightens radioresistance and thus disease recurrence and treatment failure continues to pose important challenges. However, the TME evolves under the influence of factors in systemic circulation and cellular crosstalk, underscoring its potential to be acutely and therapeutically modified. Early preclinical evidence suggests exercise may affect tumour growth and some of the benefits drawn, could act to radiosensitise tumours to treatment. Intracellular perturbations in skeletal muscle reactive oxygen species (ROS) stimulate the production of numerous factors that can exert autocrine, paracrine, and endocrine effects on the prostate. However, findings supporting this notion are limited and the associated mechanisms are poorly understood. In light of this preclinical evidence, we propose systemic changes in redox signalling with exercise activate redox-sensitive factors within the TME and improve tumour hypoxia and treatment outcomes, when combined with RT. To this end, we suggest a connection between exercise, ROS and tumour growth kinetics, highlighting the potential of exercise to sensitise tumour cells to RT, and improve treatment efficacy.
Keywords: Exercise; Hypoxia; Prostate cancer; Radiotherapy; Reactive oxygen species; Skeletal muscle.
© 2022. The Author(s).